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Only few structures for some specific metrics, such as Dmean 
rectum and D98% parotid glands exhibited deviations larger 
than 3%. g-analysis (2%, 1mm) on the three planes at 
isocenter showed a pass-rate higher than 98% for all cases. 
Clinical evaluation in ten patients showed very good 
agreement with the dose calculation on the CT as expressed 
by the D2%, D98% and Dmean of the delineated structures. 
Several drawbacks were also found: the limited FOV of the 
kV-CBCT, which impairs the dose evaluation of those 
structures in its vicinity and the difference in beam profile of 
the kV-CBCT with respect to the CT, reducing the accuracy of 
the dose estimation at nearby the surface of the patient.  
Conclusions: The generation of three kV-CBCT specific HU-
RED curves for the pelvis, thorax and H&N cases resulted in 
accurate dose calculation on kV-CBCT images. Very good 
agreement was found with the CT-based dose calculated 
plans according to DVH dose parameters and g-evaluation. 
Limitations of the kV-CBCT warrant some caution when 
evaluating dose differences for adaptive radiotherapy. 
   
OC-0165   
FSD measurements are obsolete when treating prostate 
IMRT and VMAT  
E. Forde1, J. Booth2, T. Eade2, A. Kneebone2, M. LeMotte2, M. 
Leech1 
1Trinity College Dublin, Discipline of Radiation Therapy, 
Dublin, Ireland Republic of  
2Royal North Shore Hopsital, Northern Sydney Cancer Centre, 
Sydney, Australia  
 
Purpose/Objective: Given the complexity of modulated 
fields, the validity of the traditional central axis FSD 
measurement is now being questioned. This study aims to 
quantify the impact a change in patient body contour, away 
from the central axis, has on target dose when treating dose 
escalated image guided IMRT and VMAT for definitive and 
post prostatectomy prostate cancer. 
Materials and Methods: A total of 39 patients, 22 definitive 
and 17 post prostatectomy, were included in this 
retrospective dosimetric study. Both IMRT and VMAT plans 
were calculated with a prescription dose of 80Gy and 64Gy 
for definitive and post surgical cases respectively. The 
treatment plan was applied to each of the patients’ weekly 
cone beam scans and all plans were recalculated with the 
homogeneity correction inactivated allowing for direct 
dosimetric comparison. FSDs were recorded for each IMRT 
field on each scan. The CTV D100, PTV D98, PTV D95, PTV 
D2, PTV mean and PTV median doses along with the 98% and 
95% conformity indices and homogeneity index were recorded 
for all 712 plans analyzed. Statistical analysis included 
repeated measures ANOVA and Freidman’s tests for the 
whole treatment course. Individual CBCT dependant variables 
were further analysed using paired samples T tests and 
Wilcoxon Signed Rank tests. 
Results: A total of 712 plans were created, 6408 dependant 
variables analysed and 2502 FSD measurements recorded. Of 
the FSD measurements taken from CBCTs for the IMRT plans, 
96.3% and 100% were within 1cm from the planned value for 
definitive and post prostatectomy patients respectively. For 
the definitive cohort, an increase in dose was observed 
across each metric measured (p<0.05). Subsequent analysis 
revealed 83.3% of individual measurements from CBCTs were 
significantly different (p<0.05) from the original planned 
value. For the post prostatectomy cohort only the IMRT 
homogeneity index (p=0.000) and the VMAT PTV D98 
(p=0.009), 98% (p=0.006) and 95% (p=0.002) conformity 
indices and homogeneity index (p=0.022) were significantly 
different from the planned value based on measures of 
variance. Analysis of the individual CBCTs for this group 
revealed 88% and 71.4% of endpoints measured were 
statistically similar to the original plan for IMRT and VMAT 
respectively. 
Conclusions: IMRT and VMAT beams are complex in nature. 
The endpoints analysed in this research indicate statistical 
differences to target doses despite the FSD measurements 
being within the nominal tolerance. The traditional central 
axis measurement is an insufficient indicator for dosimetric 
variation with modulated beams. As such a volumetric 
approach to contour variation, through the use of CBCT, is 
essential when treating with IMRT or VMAT. 
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Purpose/Objective: The use of IMRT for cervical cancer can 
significantly reduce dose to normal tissue. However, there is 
substantial uterine motion during treatment resulting from 
variation in bladder and rectal filling and this risk of a 
geographical miss has limited the implementation of IMRT. A 
population based CTV-PTV margin requires 15-30mm to 
ensure coverage throughout treatment but this encompasses 
large volumes of normal tissue. Daily online imaging with an 
adaptive approach may reduce margins but is very resource 
intensive. IMRT can still be safely introduced if internal 
motion throughout treatment can be accurately predicted to 
individualise volumes. 
Our aim was to assess whether variable bladder filling scans 
can be used to predict uterine position during treatment and 
compare methods for generating the final PTV. 
Materials and Methods: A retrospective analysis was 
performed of 11 patients treated with primary chemo-
radiotherapy for cervical carcinoma. Patients underwent 
‘bladder full’ radiotherapy planning scans and ‘bladder 
empty’ pre-treatment diagnostic imaging, with images co-
registered on the treatment planning software. The uterus 
and cervix were contoured on the planning scan to generate 
the CTVuterus and an isotropic 15mm expansion made to 
generate the unmodified PTVuterus. A manually modified PTV 
was made by the clinician taking into account the change in 
uterine position between scans. CBCT verification was 
performed weekly during treatment. The unmodified and 
